About Third Pole Therapeutics
Third Pole Therapeutics is a company based in Boston (United States) founded in 2014 by David Zapol.. Third Pole Therapeutics has raised $87.6 million across 5 funding rounds from investors including Avenue Capital Group. Third Pole Therapeutics offers products and services including eNOfit and Inhaled Nitric Oxide Platform. Third Pole Therapeutics operates in a competitive market with competitors including Plastiflex, Vyaire, Valencia Technologies, Resvent and Rox Medical, among others.
- Headquarter Boston, United States
- Founders David Zapol
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Third Pole, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$87.6 M (USD)
in 5 rounds
-
Latest Funding Round
$16.85 M (USD), Series B
Mar 18, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Third Pole Therapeutics
Third Pole Therapeutics offers a comprehensive portfolio of products and services, including eNOfit and Inhaled Nitric Oxide Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable system for delivering inhaled nitric oxide therapy.
Wearable device for on-demand nitric oxide delivery in treatments.
Unlock access to complete
Unlock access to complete
Funding Insights of Third Pole Therapeutics
Third Pole Therapeutics has successfully raised a total of $87.6M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $16.85 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $16.9M
-
First Round
First Round
(16 Jan 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series B - Third Pole Therapeutics | Valuation |
investors |
|
| Dec, 2022 | Amount | Series B - Third Pole Therapeutics | Valuation |
investors |
|
| Feb, 2022 | Amount | Series B - Third Pole Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Third Pole Therapeutics
Third Pole Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Avenue Capital Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investments in distressed debt and securities are managed globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Third Pole Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Third Pole Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Third Pole Therapeutics Comparisons
Competitors of Third Pole Therapeutics
Third Pole Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Plastiflex, Vyaire, Valencia Technologies, Resvent and Rox Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hose systems and related components are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Respiratory devices for diagnostics, ventilation, and patient monitoring are developed.
|
|
| domain | founded_year | HQ Location |
A coin-sized neuromodulation device for hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
A suite of respiratory healthcare devices is developed.
|
|
| domain | founded_year | HQ Location |
Develops interventional vascular therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Third Pole Therapeutics
Frequently Asked Questions about Third Pole Therapeutics
When was Third Pole Therapeutics founded?
Third Pole Therapeutics was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Third Pole Therapeutics located?
Third Pole Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Third Pole Therapeutics?
David Zapol is the current CEO of Third Pole Therapeutics. They have also founded this company.
Is Third Pole Therapeutics a funded company?
Third Pole Therapeutics is a funded company, having raised a total of $87.6M across 5 funding rounds to date. The company's 1st funding round was a Series B of $25M, raised on Jan 16, 2018.
What does Third Pole Therapeutics do?
Developer of devices for cardiopulmonary therapies. The company is developing a device offering nitric oxide (NO) from iridium electrodes for infant acute pulmonary hypertension, heart, and lung therapies. The inhaled nitric oxide therapy delivery system relaxes the blood vessels lowering the blood pressure.
Who are the top competitors of Third Pole Therapeutics?
Third Pole Therapeutics's top competitors include Valencia Technologies, Plastiflex and Vyaire.
What products or services does Third Pole Therapeutics offer?
Third Pole Therapeutics offers eNOfit and Inhaled Nitric Oxide Platform.
Who are Third Pole Therapeutics's investors?
Third Pole Therapeutics has 1 investor. Key investors include Avenue Capital Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.